Generic drugmaker Teligent files for Chapter 11, plans sale – Reuters
1 min read
Generic drugmaker Teligent files for Chapter 11, plans sale – Reuters
Generic drugmaker Teligent Inc filed for bankruptcy protection on Thursday with plans to sell itself, citing “regulatory and legal setbacks” including a warning letter from the U.S. Food and Drug Administration related to its manufacturing processes.